Skip to main content
PMC home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1993 May;36(3):149–155. doi: 10.1007/BF01741085

The role of apoptosis in antibody-dependent cellular cytotoxicity

S John Curnow 1, Martin J Glennie 1, George T Stevenson 1,✉
PMCID: PMC11038708  PMID: 8439975

Abstract

Apoptosis in three lymphoma cell lines has been studied following cytotoxicity induced in vitro by normal human blood lymphocytes utilizing either natural killer (NK) or antibody-dependent cellular cytotoxic (ADCC) mechanisms. Guinea-pig L2C leukaemic lymphocytes, but not the human cell lines Daudi and Jurkat, revealed a degree of time- and temperature-dependent apoptotic death upon simple culture in vitro. NK cytotoxicity at low effector: target ratios (E: T) induced both release of51Cr and apoptosis. However NK cytotoxicity at higher E : T, and ADCC at all E : T, increased the level of51Cr release while reducing the level of apoptosis. The findings were consistent with the apoptotic process being cut short by intervention of necrotic death. The same characteristics accompanied ADCC whether the effectors were recruited by Fcγ regions of antibody coating the targets, or by bispecific antibodies attaching one arm to the targets and the other to Fcγ receptors type III on effectors. This finding, and the high level of cytotoxicity elicited by the bispecific method, confirm the belief that NK cells, in addition to exerting NK cytotoxicity, represent the principal effectors for ADCC among blood mononuclear cells. Our results suggest that NK cells have both apoptotic and necrotic mechanisms available for killing their targets, but use only the latter for ADCC.

Key words: Apoptosis, DNA fragmentation, Cellular cytotoxicity, NK cells

References

  • 1.Baxter GD, Collins RJ, Harmon BV, Kumar S, Prentice RL, Smith PJ, Lavin MF. Cell death by apoptosis in acute leukaemia. J Pathol. 1989;158:123–129. doi: 10.1002/path.1711580207. [DOI] [PubMed] [Google Scholar]
  • 2.Berke G. Lymphocyte-triggered internal target disintegration. Immunol Today. 1991;12:396–399. doi: 10.1016/0167-5699(91)90138-j. [DOI] [PubMed] [Google Scholar]
  • 3.Collins RJ, Verschuer LA, Harmon BV, Prentice RL, Pope JH, Kerr JF. Spontaneous programmed cell death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br J Haematol. 1989;71:343–350. doi: 10.1111/j.1365-2141.1989.tb04290.x. [DOI] [PubMed] [Google Scholar]
  • 4.Duke RC, Chervenak R, Cohen JJ. Endogenous endonucleaseinduced DNA fragmentation: an early event in cell-mediated cytolysis. Proc Natl Acad Sci USA. 1983;80:6361–6365. doi: 10.1073/pnas.80.20.6361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Duke RC, Cohen JJ, Chervanek R. Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells. J Immunol. 1986;137:1442–1447. [PubMed] [Google Scholar]
  • 6.Duke RC, Persechini PM, Chang S, Liu CC, Cohen JJ, Young JD. Purified perforin induces target cell lysis but not DNA fragmentation. J Exp Med. 1989;170:1451–1456. doi: 10.1084/jem.170.4.1451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Duvall E, Wyllie AH, Morris RG. Macrophage recognition of cells undergoing programmed cell death (apoptosis) Immunol. 1985;56:351–358. [PMC free article] [PubMed] [Google Scholar]
  • 8.Elliott TJ, Glennie MJ, McBride HM, Stevenson GT. Analysis of the interaction of antibodies with immunoglobulin idiotypes on neoplastic B lymphocytes; implications for immunotherapy. J Immunol. 1987;138:981–988. [PubMed] [Google Scholar]
  • 9.Fleit HB, Wright SD, Unkeless JC. Human Fc gamma receptor distribution and structure. Proc Natl Acad Sci USA. 1982;79:3275–3280. doi: 10.1073/pnas.79.10.3275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Glennie MJ, McBride HM, Worth AT, Stevenson GT. Preparation and performance of bispecific F(ab′γ)2 antibody containing thioether-linked Fab′γ fragments. J Immunol. 1987;139:2367–2375. [PubMed] [Google Scholar]
  • 11.Greenman J, Hogg NM, Nikoletti SM, Slade CJ, Stevenson GT, Glennie MJ. Comparative efficiencies of bispecific F(ab′γ)2 and chimeric mouse/human IgG antibodies in recruiting cellular effectors for cytotoxicity via Fcγ receptors. Cancer Immunol Immunother. 1992;34:361–369. doi: 10.1007/BF01741745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gromkowski SH, Brown TC, Cerutti PA, Cerottini JC. DNA of human Raji target cells is damaged upon lymphocyte-mediated lysis. J Immunol. 1986;136:752–756. [PubMed] [Google Scholar]
  • 13.Ishigami T, Kim KM, Horiguchi Y, Higaki Y, Hata D, Heike T, Katamura K, Mayumi M, Mikawa H. Anti-IgM antibody-induced cell death in a human B-lymphoma cell line, B104, represents a novel programmed cell death. J Immunol. 1992;148:360–368. [PubMed] [Google Scholar]
  • 14.Karpovsky B, Titus JA, Stephany DA, Segal DM. Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fcγ receptor antibodies. J Exp Med. 1984;160:1686–1701. doi: 10.1084/jem.160.6.1686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications for tissue kinetics. Br J Cancer. 1972;26:239–257. doi: 10.1038/bjc.1972.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Klein E, Klein G, Nadkarni JS, Nadkarni JJ, Wigzell H, Clifford P. Surface IgM-kappa specificity on a Burkitt lymphoma cell line in vivo and in derived culture lines. Cancer Res. 1968;28:1300–1310. [PubMed] [Google Scholar]
  • 17.Krahenbuhl O, Tschopp J. Perforin-induced pore formation. Immunol Today. 1991;12:399–403. doi: 10.1016/0167-5699(91)90139-k. [DOI] [PubMed] [Google Scholar]
  • 18.Lamoyi E, Nisonoff A. Preparation of F(ab′)2 fragments from mouse IgG of various subclasses. J Immunol Methods. 1983;56:235–243. doi: 10.1016/0022-1759(83)90415-5. [DOI] [PubMed] [Google Scholar]
  • 19.Liu Y, Mullbacher A, Waring P. Natural killer cells and cytotoxic T cells induce DNA fragmentation in both human and murine target cells in vitro. Scand J Immunol. 1989;30:31–37. doi: 10.1111/j.1365-3083.1989.tb01185.x. [DOI] [PubMed] [Google Scholar]
  • 20.McConkey DJ, Chow SC, Orrenius S, Jondal M. NK cell-induced cytotoxicity is dependent on a Ca2+ increase in the target. FASEB J. 1990;4:2661–2664. doi: 10.1096/fasebj.4.9.2347464. [DOI] [PubMed] [Google Scholar]
  • 21.Moore K, Cooper SA, Jones DB. Use of the monoclonal antibody WR17 identifying the CD37 gp40–45 Kd antigen complex in the diagnosis of B-lymphoid malignancy. J Pathol. 1987;152:13–21. doi: 10.1002/path.1711520103. [DOI] [PubMed] [Google Scholar]
  • 22.Robaye B, Mosselmans R, Fiers W, Dumont JE, Galand P. Tumour necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol. 1991;138:447–453. [PMC free article] [PubMed] [Google Scholar]
  • 23.Shi L, Kraut RP, Aebersold R, Greenberg AH. A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med. 1992;175:553–556. doi: 10.1084/jem.175.2.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Stacey NH, Bishop CJ, Halliday JW, Cooksley WGE, Powell LW, Kerr JFR. Apoptosis as the mode of cell death in antibody-dependent lymphocytotoxicity. J Cell Sci. 1985;74:169–179. doi: 10.1242/jcs.74.1.169. [DOI] [PubMed] [Google Scholar]
  • 25.Stevenson GT, Eady RP, Hough DW, Jurd RD, Stevenson FK. Surface immunoglobulin of guinea-pig leukaemic lymphocytes. Immunology. 1975;28:807–820. [PMC free article] [PubMed] [Google Scholar]
  • 26.Willams GT. Programmed cell death: apoptosis and oncogenesis. Cell. 1991;65:1097–1098. doi: 10.1016/0092-8674(91)90002-g. [DOI] [PubMed] [Google Scholar]
  • 27.Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. doi: 10.1016/s0074-7696(08)62312-8. [DOI] [PubMed] [Google Scholar]
  • 28.Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol. 1984;142:67–77. doi: 10.1002/path.1711420112. [DOI] [PubMed] [Google Scholar]
  • 29.Young JD-E. Killing of target cells by lymphocytes: a mechanistic view. Physiol Rev. 1989;69:250–314. doi: 10.1152/physrev.1989.69.1.250. [DOI] [PubMed] [Google Scholar]
  • 30.Young JD-E, Cohn ZA, Podack ER. The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological and functional similarities. Science. 1986;233:184–190. doi: 10.1126/science.2425429. [DOI] [PubMed] [Google Scholar]
  • 31.Zychlinsky A, Zheng LM, Liu C, Young JD. Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. J Immunol. 1991;146:393–400. [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES